MRC Centre for Causal Analyses in Translational Epidemiology, University of Bristol, Bristol, United Kingdom.
Am J Clin Nutr. 2011 Jul;94(1):149-55. doi: 10.3945/ajcn.110.010751. Epub 2011 May 18.
Gestational weight gain (GWG) is associated with a range of health outcomes, but little is known about the factors that influence it.
The objective was to test the hypothesis that maternal and fetal genetic variants that are reliably associated with adiposity are associated with GWG.
We examined the association of a risk allele score by using 4 adiposity-related single nucleotide polymorphisms (SNPs; rs9939609 in FTO, rs17782313 near MC4R, rs6548238 near TMEM18, and rs10938397 near GNPDA2) with GWG in a pregnancy cohort in which women had detailed repeated assessment of GWG (median number of weight measurements: 10; interquartile range: 8, 11). The numbers included in our analyses varied between 2324 and 7563 for different variant-outcome analyses. A linear spline random-effects model was used to model weight change with gestational age and to relate genetic variants to this. This modeling confirmed 3 distinct periods of GWG: 0-18, 19-28, and ≥29 wk of gestation.
Maternal risk allele score and SNPs in FTO, MC4R, and TMEM18 were positively associated with prepregnancy weight. Maternal allele score was inversely associated with GWG in the first 18 wk of pregnancy (-14.46 g/wk per allele; 95% CI: -24.75, -4.17 g/wk per allele) but was not associated with other periods of GWG. Offspring allele score and maternal and offspring individual SNPs were not associated with GWG in any period or with birth weight or postnatal weight retention.
Our findings suggest that neither maternal nor fetal adiposity-related genetic variants are associated with greater GWG. The inverse association of maternal allele score with GWG in the first 18 wk requires replication.
妊娠体重增加(GWG)与一系列健康结果相关,但人们对影响 GWG 的因素知之甚少。
本研究旨在检验以下假设,即与肥胖相关的母体和胎儿遗传变异与 GWG 相关。
我们使用 4 个与肥胖相关的单核苷酸多态性(SNP)(FTO 中的 rs9939609、MC4R 附近的 rs17782313、TMEM18 附近的 rs6548238 和 GNPDA2 附近的 rs10938397)的风险等位基因评分,对 GWG 进行了妊娠队列的关联分析,该队列中女性对 GWG 进行了详细的重复评估(GWG 测量的中位数次数:10;四分位间距:8,11)。不同变异-结局分析的纳入人数在 2324 至 7563 之间不等。线性样条随机效应模型用于模拟体重随妊娠龄的变化,并将遗传变异与体重变化相关联。该模型确认 GWG 存在 3 个不同时期:0-18、19-28 和≥29 孕周。
母体风险等位基因评分和 FTO、MC4R 和 TMEM18 中的 SNP 与孕前体重呈正相关。母体等位基因评分与妊娠前 18 周的 GWG 呈负相关(每个等位基因减少 14.46 克/周;95%CI:-24.75,-4.17 克/周),但与其他 GWG 时期无关。后代等位基因评分以及母体和后代的单个 SNP 与任何时期的 GWG、出生体重或产后体重保留均无关联。
我们的研究结果表明,母体和胎儿肥胖相关的遗传变异与 GWG 增加无关。母体等位基因评分与 GWG 在妊娠前 18 周的负相关关系需要进一步验证。